ABSTRACT The bacterial cell surface is the first structure the host immune system targets to prevent infection. Cationic antimicrobial peptides of the innate immune system bind to the membrane of Gram-negative pathogens via conserved, surfaceexposed lipopolysaccharide (LPS) molecules. We recently reported that modern strains of the global intestinal pathogen Vibrio cholerae modify the anionic lipid A domain of LPS with a novel moiety, amino acids. Remarkably, glycine or diglycine addition to lipid A alters the surface charge of the bacteria to help evade the cationic antimicrobial peptide polymyxin. However, the regulatory mechanisms of lipid A modification in V. cholerae are unknown. Here, we identify a novel two-component system that regulates lipid A glycine modification by responding to important biological cues associated with pathogenesis, including bile, mildly acidic pH, and cationic antimicrobial peptides. The histidine kinase Vc1319 (VprB) and the response regulator Vc1320 (VprA) respond to these signals and are required for the expression of the almEFG operon that encodes the genes essential for glycine modification of lipid A. Importantly, both the newly identified two-component system and the lipid A modification machinery are required for colonization of the mammalian host. This study demonstrates how V. cholerae uses a previously unknown regulatory network, independent of well-studied V. cholerae virulence factors and regulators, to respond to the host environment and cause infection.
V
ibrio cholerae is the etiological agent of cholera, a potentially lethal diarrheal disease that infects millions of people every year. There have been seven recorded cholera pandemics. The first six cholera pandemics were caused by the V. cholerae classical biotype. The current 7th pandemic is caused by the V. cholerae El Tor biotype that globally displaced the classical biotype during the end of the 20th century and represents the largest recorded evolutionary change in V. cholerae epidemiology (1, 2) .
El Tor V. cholerae is endemic to many regions of the developing world, causing seasonal and sporadic outbreaks. V. cholerae lives in aquatic reservoirs and enters the human host orally through consumption of contaminated food or water. Following colonization of the small intestine, V. cholerae secretes cholera toxin, which causes the profuse and potentially lethal diarrhea characteristic of cholera disease (3) . Modeling of cholera epidemics has implicated both environmental transfer and person-to-person transfer as important factors in disease spread (4, 5) .
The human gastrointestinal tract possesses different barriers to impede colonization of pathogenic microorganisms such as V. cholerae. These include gastric acid barrier of the stomach, bile, and cationic antimicrobial peptides (CAMPs) produced by the host immune system (6, 7) . While CAMPs vary in composition and structure, their bactericidal effect involves the electrostatic interaction between the peptide and the target outer membrane of Gram-negative bacteria (6, 8) . This interaction allows the peptide to be inserted into the bilayer structure, leading to increased bacterial membrane permeability and ultimately bacterial lysis (8) .
We previously reported that El Tor strains modify lipid A with glycine or diglycine residues to increase the net positive charge to prevent binding of CAMPs in V. cholerae (Fig. 1) . In fact, glycine addition to the lipid A of O1 El Tor and O139 strains confers a high level of resistance to the CAMP polymyxin, whereas the O1 classical biotype, which lacks the glycine modification machinery, is sensitive to polymyxin (9) . The difference was used to distinguish between the two pathogenic strains, but for 50 years the mechanism for this resistance was unknown. Our previous report identified 3 aminoacyl lipid modification (alm) genes, almEFG, which are required for glycine/diglycine addition in O1 El Tor strains and therefore responsible for their unique polymyxin resistance. These genes are cotranscribed, and disruption of any of the three results in an~100-fold decrease in polymyxin resistance (9) . Recently, our laboratory has elucidated the initial steps in the addition of glycine to lipid A via structural and biochemical studies (10) . In summary, AlmF functions as a carrier protein and contains a phosphopantetheine residue. The almE gene encodes the glycine carrier ligase AlmE, which attaches a glycine residue to the phosphopantetheine group of AlmF, which in turn transfers the glycine moiety to the receptor protein AlmG. Ultimately, AlmG catalyzes the transfers of glycine to the hexa-acylated V. cholerae lipid A, promoting the resistance to polymyxin (see Fig. 7 ). Finally, expression of the almEFG system in the classical biotype results in a significant increase in polymyxin resistance. This demonstrates that lipid A modifications are evolving in ongoing bacterial pathogen pandemics and highlights the importance of examining lipid A structures.
Lipid A is synthesized via a well-conserved mechanism, known as the Raetz pathway (11) . In model microorganisms such as Salmonella and Escherichia coli, the lipid A domain of LPS is a ␤-1=,6-linked disaccharide of glucosamine that is hexa-acylated and bisphosphorylated. During growth in rich medium, a portion of lipid A contains a pyrophosphate group at the 1 position, yielding a tris-phosphorylated species (12, 13) (Fig. 1) . The polysaccharide portion of LPS extends from the lipid anchor at the 6= position of the distal sugar. In E. coli and Salmonella, modification of lipid A in response to CAMPs results in loss of the tris-phosphorylated lipid A species and addition of the positively charged residues phosphoethanolamine (pEtN) or L-4-aminoarabinose (Ara4N) (Fig. 1) (12, 14) . Other modifications include the addition of a palmitate chain and, in Salmonella, the addition of a hydroxyl group to the 3= secondary myristoyl chain ( Fig. 1) (15-17) .
To understand how Vibrio regulates its LPS structure and to reveal additional mechanisms of antimicrobial peptide resistance, we screened the O1 El Tor nonredundant transposon (Tn) library (18) for mutants with increased sensitivity to polymyxin B. From this analysis, a VC1320-VC1319 two-component system (TCS) was identified and shown to promote polymyxin resistance by hexa-acylated and phosphorylated at the 1 and 4= positions. The phosphate groups of E. coli and S. enterica lipid A can be modified with the amine-containing moieties L-4-aminoarabinose and phosphoethanolamine, shown in red. Also, a palmitate residue 16 carbons in length (shown in black) can be added to the 2 position, yielding a hepta-acylated structure. In S. enterica, a hydroxyl group is added to the 3=-linked secondary acyl chain at the 2 position, yielding a 2-OH myristate. V. cholerae can be modified with either glycine or diglycine residues attached to the 3-OH group of the secondary acyl chain attached at the 3= position.
controlling the regulatory pathway for lipid A modification. This VC1320-VC1319 (VprAB) TCS directly regulates expression of the alm operon, which encodes proteins essential for glycine modification of lipid A. Furthermore, mutants in lipid A glycinylation and its regulation display significantly reduced fitness during mammalian intestinal colonization. Despite a plethora of research on E. coli and Salmonella lipid A regulation, this is the first study to characterize the regulatory factors that control the V. cholerae lipid A structure. The VprAB TCS is distinct from those found in E. coli and Salmonella, and its role in endotoxin modulation promotes pathogenesis. This characterization identifies VprAB as a virulence regulatory system that functions alongside studied V. cholerae virulence networks such as the ToxR regulon (19) . Beyond determining new virulence factors in V. cholerae, this work validates that LPS remodeling and its regulation play an important role in promoting bacterial survival in the mammalian host.
RESULTS
Identification of polymyxin-sensitive mutants in V. cholerae O1 El Tor. To identify the regulatory mechanisms required for antimicrobial resistance, we screened the V. cholerae O1 El Tor nonredundant transposon library for mutants increased in sensitivity to the CAMP polymyxin B (18) . We identified mutants that were susceptible to subinhibitory concentrations of polymyxin (50 g/ ml) grown in Luria broth (LB) medium. Eleven transposon mutants exhibited limited growth (optical density at 600 nm [OD 600 ] of Ͻ0.2) after 24 h (Table 1 ). All identified mutant strains showed growth rates similar to that of the wild type in the absence of polymyxin B (data not shown). Further analysis determined the MIC using gradient polymyxin B E-strips in LB agar medium to confirm the antimicrobial peptide-related phenotype (Table 1 and Fig. 2 ). Wild-type El Tor (strain C6706) is highly resistant to polymyxin B, displaying a MIC of 128 g/ml, whereas all selected Table S2 in the supplemental material) expressing the wild-type (ϩ) or mutated alleles (subscript) in trans. The MIC value is indicated with a white arrow. Data are representative of three biological repetitions.
mutants showed a drastic reduction in resistance ( Table 1 ). Some of the identified genes were previously reported to be required for V. cholerae El Tor polymyxin resistance, thus validating our screening method (9, 20) . For example, the screen identified vc1579 (almE) and vc1578 (almF) ( Table 1) , which are part of the alm operon (vc1579-78-77) and are required for the addition of glycine and diglycine residues to V. cholerae lipid A ( Fig. 1 ; see also Fig. 7 ) (9) . It is important to note that vc1577 (almG) was not identified in this screen, because the Tn insertion occurs in the last 1% of the coding region, most likely resulting in a functional but truncated gene product. Additionally, the vc0212 (lpxN) gene was identified (Table 1) , which encodes the hydroxyacyltransferase responsible for the addition of a 3-hydroxylaurate (3-OH C12:0) to the primary acyl chain linked at the 3= position of Vibrio lipid A (20) . The 3-OH group of this secondary fatty acid serves as the attachment site for glycine/diglycine ( Fig. 1 ) and is required for polymyxin resistance (9) . Accordingly, these mutants exhibited drastic reduction in resistance to polymyxin (Table 1) , as previously reported by our laboratory (MIC of 0.5 to 1.5 g/ml) (9, 20) . Mutants in genes vc2728 (gspI), vc2731 (gspF), and vc2732 (gspE) also exhibited sensitivity to polymyxin (Table 1) . These genes are included in a transcriptional unit of 10 genes which encode components of the V. cholerae type II secretion system (T2SS) (21) . Previous studies have demonstrated that V. cholerae T2SS mutants exhibit compromised outer membrane integrity and increased sensitivity to antimicrobial peptides (22) . Additional transposon mutants include genes that have not been previously associated with polymyxin resistance. The gene vc0224 encodes a putative LPS glycosyltransferase, and nearby the vc0239 gene was also identified, with an 85-and 21-fold reduction in MIC, respectively (23) . Analysis of LPS of these strains by SDS-PAGE indicated truncation of the core oligosaccharide of V. cholerae LPS (see Fig. S1 in the supplemental material). Complementation analyses confirmed that these genes contribute to polymyxin resistance (Table 1) . Mutants with only partial complementation (vc2728, vc0239, and vc1578) may indicate that the transposon insertion induces polar effects on downstream genes.
The vc1319 and vc1320 genes identified in the screen are predicted to be cotranscribed in an operon according to ProOpDB analysis (23) . The vc1319 gene encodes a putative sensor histidine kinase and vc1320 a putative response regulator, which suggests they comprise a two-component system (TCS). The vc1320-vc1319 operon is widely conserved among Vibrio cholerae strains, including classical and El Tor biotypes (see Table S1 in the supplemental material). vc1319 and vc1320 mutants exhibited a 64-and 85-fold reduction in polymyxin B MIC values, respectively (Table 1, Fig. 2 ). Complementation of either mutation restored wild-type resistance or greater, indicating that each gene is required for resistance to polymyxin B (Table 1, Fig. 2) .
The vc1320-vc1319 operon is required for lipid A glycinylation. The addition of glycine or diglycine moieties to lipid A ( Fig. 1 ) improves resistance to polymyxin by Ͼ100-fold (9) . Our polymyxin sensitivity screen suggested a possible link between the vc1320-vc1319 operon and the modification of lipid A. To evaluate this further, lipid A species from El Tor strain C6706 and derived strains were isolated and evaluated using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. Lipid A from the wild type exhibited a minor peak at m/z 1,757.1, characteristic of unmodified hexa-acylated lipid A in V. cholerae biotype El Tor, and predominant peaks at m/z 1,813.2 and 1,870.2 corresponding to glycine and diglycine addition to lipid A (Fig. 3A) (9) . In the absence of functional genes vc1319 or vc1320, mutant strains exhibited a major peak at m/z 1,755.6 and 1,756.1 ( Fig. 3B and C) and loss of peaks representative of glycinemodified lipid A molecules. Both glycine addition and diglycine addition were observed in complemented strains (Fig. 3D ). These results confirm that Vc1319 and Vc1320 are required for lipid A modification, and given their homology to a prototypical TCS, these proteins may regulate expression of the glycine modification machinery.
Vc1320-Vc1319 (VprA-VprB) directly regulates expression of the almEFG operon. TCSs form regulatory switches where a phosphotransfer reaction between two proteins, the histidine kinase and the response regulator, is required to regulate downstream events (24) . We hypothesized that Vc1319-Vc1320 forms a cognate TCS that regulates polymyxin resistance, and therefore mutation of conserved amino acids predicted to be TCS phosphorylation sites should affect polymyxin resistance (24, 25) . Thus, highly conserved residues in Vc1319-Vc1320 consistent with phosphotransfer activity were identified through multiplesequence alignment with proteins in related TCS and mutated (see were both mutated to alanine, and polymyxin MIC assays were evaluated. In each case, expression of the single-site alanine variant allele at otherwise wild-type levels resulted in a 42-fold reduction in polymyxin B MIC (Fig. 2) . These results, along with what has been described in other TCSs, indicate that H 222 in the Vc1319 histidine kinase and D 55 in the Vc1320 response regulator are the essential phosphorylation sites. This result suggests that Vc1320-Vc1319 is a signaling pair that promotes resistance to polymyxin, here named the VprA-VprB (Vibrio polymyxin resistance) twocomponent system.
To verify that VprAB regulates lipid A modification via the control of almEFG synthesis, we evaluated the relative expression of almE in different mutant backgrounds. Quantitative PCR (qPCR) analysis showed that expression of the almE transcript decreased 70-fold in the vprA mutant and 6.7-fold in the vprB mutant relative to almE expression in the wild type (Fig. 4A ). The level of almE transcripts could be restored in both vprB and vprA mutants when the corresponding vpr gene was complemented in trans. While almE expression was only partially recovered, it was sufficient to provide resistance to polymyxin at wild-type levels ( Fig. 2 ).
An essential step in defining a TCS is identifying genes it directly regulates. To evaluate whether the VprA response regulator directly binds to the promoter region of almE (P almE ), we generated a C-terminally His 6 -tagged VprA protein (VprA-His 6 ) and assayed its ability to bind to P almE . VprA-His 6 successfully complemented the vprA mutant, restoring polymyxin resistance (see Table S2 in the supplemental material), and was purified by nickel affinity chromatography (see Fig. S3 in the supplemental material). A 32 P-labeled nucleotide probe consisting of the~130-bp upstream region of the almE gene ( 32 P-P almE ) was used for DNA binding experiments, including differential radial capillary action of ligand assay (DRaCALA) (26) and gel mobility shift assays (electrophoretic mobility shift assay [EMSA]).
DRaCALA measures protein-DNA binding interactions by measuring the radial capillary action of DNA spotted on a nitrocellulose membrane. DNA-protein complexes show less mobility on the membrane than unbound DNA. In our experiment, the mobility of 32 P-P almE decreased as increasing concentrations of VprA-His 6 were added (Fig. 4B) , indicating that VprA binds to the promoter region of almE. VprA binding to 32 P-P almE was unaffected by nonspecific DNA and was minimized if 10-fold excess of nonlabeled P almE was included in the assay (Fig. 4B) .
Complex formation between the P almE and VprA-His 6 was also verified by EMSA (Fig. 4C) . VprA-His 6 retards the mobility of 32 P-P almE in the gel mobility shift assay compared to 32 P-P almE alone (Fig. 4C, lanes 1 and 2) . The nature of this specific binding was confirmed by adding 10-fold-excess unlabeled P almE to the assay. The unlabeled DNA competes for VprA-His 6 binding and therefore reduces the degree of 32 P-P almE shifting (Fig. 4C, lane 3) . A nonspecific sequence competitor was also used in 10-fold excess without affecting the formation of the VprA 32 P-P almE complex (Fig. 4C, lane 4) . Together, these results demonstrated that VprA directly binds to the promoter region of the almEFG operon concordant with the system's role in lipid A glycinylation.
Interestingly, in Salmonella, the lipid A modification regulatory pathway also includes genes that build or modify LPS structural components, like O-antigen polysaccharides and core (27) (28) (29) . We therefore evaluated whether the VprAB TCS also influenced LPS assembly, as a truncation in the LPS structure might contribute to the observed phenotypes for polymyxin resistance and colonization. The LPS profile was compared between wild-type, vprA, vprB, and almE mutant strains using SDS-PAGE. Similar LPS migration patterns were observed in vprA and vprB mutants and in the wild type, suggesting that mutations in the VprAB regulatory pathway do not impact LPS assembly (see Fig. S4 in the supplemental material).
The VprA-VprB two-component system responds to polymyxin, bile, and mildly acidic pH. Two-component systems found in S. enterica and E. coli that are involved in LPS modification respond to different environmental signals, such as antimicrobial peptides, presence of metals (e.g., Mg 2ϩ , Fe 3ϩ ), and changes in pH (30) (31) (32) . Therefore, to identify environmental cues that the VprAB TCS responds to, the levels of vprA and almE transcripts were evaluated in V. cholerae grown in medium supplemented with specific extracellular signals. Wild-type cells grown in LB medium in the presence of a sublethal polymyxin B concentration (1 g/ml) significantly upregulated vprA and almE transcripts, suggesting that in response to environmental CAMPs, El Tor cells can elicit a protective response (Fig. 5) . Alternatively, when wild-type cells were exposed to divalent cations such as Ca 2ϩ (10 mM) and Mg 2ϩ (10 mM), vprA and almE synthesis were downregulated. Statistically significant changes were observed only in almE transcripts (see Fig. S5A in the supplemental material), suggesting that V. cholerae moderately responds to divalent cations with a concomitant reduction in glycine-lipid A modification. Wild-type cells grown in the presence of iron Fe 3ϩ (40 M), however, did not show a significant change in the level of either vprA or almE transcripts (see Fig. S5A ). With respect to pH, wildtype cells grown under mildly acidic conditions using pH 5.8-buffered LB medium showed a 3.0-fold decrease in vprA and almE synthesis compared to that of pH 7.0-buffered LB (Fig. 5 ). These observations suggest that the VprAB TCS may be responding to changes in the environment beyond antimicrobial peptides.
Conditions that mimic the lumen of the intestine are particularly relevant environmental cues to study in V. cholerae. Bile is a mixture of many molecules, such as saturated and unsaturated fatty acids, salts, and cholesterol, that is secreted into the lumen of the human intestine, aiding in the emulsification of lipids (33) . The current model of V. cholerae virulence gene expression indicates that cells navigating the intestinal lumen, and therefore exposed to bile, consistently downregulate virulence gene expression (34, 35) . It is not until the cells pass through the mucous layer coating the intestinal epithelia, and are therefore shielded from bile, that virulence gene expression is activated (34, 35) . As V. cholerae has been shown to alter cell envelope components in response to bile, we examined the effect of crude bile on both vprA and almE regulation. Wild-type cells were exposed to a subinhibitory concentration of bile (0.2% bile) or specific bile salts. A strong downregulation of both vprA (5-fold) and almE (5.5-fold) transcripts was observed in the presence of crude bile or bile salts (Fig. 5) . Further evaluation of cells lacking vprA or vprB genes confirmed that almE synthesis requires VprAB to respond to polymyxin, bile, and mildly acidic pH (see Fig. S5B , C, and D in the supplemental material). These data demonstrate that vprAB and almEFG operons are constitutively synthesized in rich medium, but key environmental cues can alter almEFG expression through a VprABdependent mechanism. Most significantly, the repression of almE in bile indicates it has a virulence gene expression profile and that the lipid A glycinylation system is a potential virulence factor in vivo.
Glycine-modified lipid A is required for intestinal colonization. Previous work has demonstrated that lipid A modification is an important virulence determinant for colonization of Helicobacter pylori, Legionella pneumophila, Salmonella enterica, and Campylobacter jejuni during mammalian infection (36) (37) (38) (39) . However, little is known regarding the role of V. cholerae lipid A modification in host colonization. To determine whether VprAB-and AlmE-dependent lipid A modifications are required for pathogen-
FIG 4
The VprA-VprB two-component system directly regulates almE synthesis. (A) The VprA-VprB two-component system is required for synthesis of the almEFG operon. Expression of almE was determined by qPCR in wild-type, vprA::Tn, vprA::Tn, vprB ϩ , and vprA ϩ strains grown in LB. All cells were harvested during log phase, followed by total RNA extraction. The expression of each gene was normalized using gyrA as the reference gene. The data show the average from three biological repetitions. *, statistical significance was calculated using a t test (P Ͻ 0.05). (B and C) The transcriptional regulator VprA-His 6 binds the promoter of almE (P almE ). (B) Differential radial capillary action of ligand assay (DRaCALA) was used to demonstrate that increasing concentrations of VprA-His 6 promote binding to the P almE region, restricting the radial complex dispersion of the 32 P-labeled promoter region of almE ( 32 P-P almE ). Total mobility of the double-stranded 32 P-P almE without protein served as a negative control (far left). Reduction in protein-32 P-DNA binding is observed when a specific competitor is included in the reaction, but the DNA binding is restored in the presence of a nonspecific competitor (far right). (C) Electrophoretic mobility shift assay (EMSA). A VprA-His 6 -P almE binding complex is observed as a shifted migration (lane 2) compared to free probe (lane 1). A specific competitor decreased the observed shift intensity (lane 3), whereas a nonspecific competitor allowed formation of the DNA-protein complex (lane 4). esis, the suckling mouse model was used to measure V. cholerae intestinal colonization. Transposon mutants of vprA and almE were competed against their wild-type background strain C6706 for their ability to colonize the suckling mouse small intestine. Remarkably, the vprA mutant exhibits a 34-fold fitness defect (P value of 2.6EϪ09), and even more striking, the almE mutant exhibited a 363-fold fitness defect (P value of 7.4EϪ17) in intestinal colonization (Fig. 6 ). These data demonstrate that the lipid A glycine modification machinery, as well as its regulating VprAB TCS, are important virulence factors in vivo.
Since different El Tor strains have shown various behaviors during mouse colonization (40), our in vivo competition assays were extended to the El Tor E7946 background. The almEFG operon was originally identified in the E7946 background, so examining the in vivo contribution of the newly identified VprAB TCS in that same background was of particular interest to us (9) . We generated an unmarked nonpolar deletion in the transcriptional regulator, yielding the E7946 ⌬vprA strain (see Table S3 in the supplemental material). The ⌬vprA mutant exhibited a growth rate similar to that of the wild type and was sensitive to polymyxin (see Table S2 in the supplemental material), comparable to the C6706 vprA::Tn strain (Table 1) . Also, the lipid A profile of the E7946 ⌬vprA mutant showed complete loss of glycine/diglycine modification, identical to the C6706 vprA::Tn strain (Fig. 3) . In mouse competition assays, the E7946 ⌬vprA strain showed a 31-fold colonization defect (P value of 4.9EϪ10) (Fig. 6 ). For completeness, several attempts were made to obtain an unmarked deletion of almE or the complete alm operon in the E7946 background. However, we were unsuccessful after many attempts. Collectively, the colonization data support that VprABdependent regulatory mechanisms are involved in pathogenicity FIG 5 Changes in vprA and almE transcription during different growth conditions. Transcript levels of vprA and almE were determined in C6706 wild-type cells using qPCR. Cells were grown in LB medium or LB supplemented with 1 g/ml polymyxin B, 0.2% bile, or specific bile components. For pH effect, buffered LB adjusted to pH 7.0 and 5.8 was used. Total RNA was isolated from cells at mid-exponential growth phase. Target gene expression was normalized to the gyrA gene. Error bars represent standard deviations from three biological replicates. *, statistical significance is indicated at P values of Ͻ0.05.
FIG 6
Glycine-dependent lipid A modification contributes to intestinal colonization. The ability of strains defective in glycine-lipid A modification to colonize the suckling mouse was evaluated by competition with the corresponding isogenic wild-type El Tor strain (E7946 or C6706). Each data point represents the ratio of mutant to wild-type bacteria after colonization of one mouse. A competitive index of 1, as indicated by a dashed line, is representative of no fitness defect. Significance (P Ͻ 0.0001) was determined by Student's t test. and notably demonstrated the significance of alm-dependent lipid A modification during host colonization.
DISCUSSION
Despite elucidation of various antimicrobial peptide resistance mechanisms in bacteria, our knowledge of intrinsic and mutation-driven resistance of Vibrio to polymyxin is limited. We screened the El Tor C6706 ordered transposon mutant library for mutants sensitive to subinhibitory levels of polymyxin B. Our screen identified several genes previously known to participate in polymyxin B resistance and also revealed a number of uncharacterized genes. Many of the genes identified (almE, almF, lpxN, vc0239, and vc0224) are known to contribute to LPS biosynthesis and modification. Other genes (vc2728, vc2731, and vc2732) were part of the T2SS and are known to contribute to membrane stability (22, 41, 42) . This finding is consistent with the importance of regulating LPS structure to maintain membrane stability, particularly in the presence of CAMPs (31, 43, 44) . The gene vc1981 was also identified and is a member of the rhomboid protease family showing structural similarity to E. coli GlpG. However, the role this protease plays in polymyxin resistance is unknown and is under investigation by our laboratory.
Our screen identified only a small repertoire of genes (Table 1 ) important for polymyxin B resistance, consistent with an equally limited number of polymyxin resistance determinants found in Pseudomonas (45) . The screened mutant library does not include essential genes, however, and such genes likely contribute to the polymyxin resistance phenotype. Additionally, some transposon insertions may disrupt only nonessential domains of the gene (9) . Although the mutant library screen has some limitations, it is remarkable how few genes contribute to polymyxin resistance. This may indicate the importance of the VprAB regulatory system as the main protective response to CAMPs. Also, glycinylation of lipid A is unique compared to the well-studied amino-arabinose modification system observed in Salmonella, E. coli (16, 46) , Pseudomonas (47) , Yersinia (48), Burkholderia (49) , and Bordetella (50) . Interestingly, glycine modification is found in the El Tor O1 strains dominating the current cholera pandemic but not in the classical Vibrio biotype, indicating that lipid A remodeling may be under evolutionary selection pressure in ongoing contagions.
This study identified a new two-component regulatory system, named VprAB, involved in antimicrobial peptide resistance. It is notable that this is the only putative TCS that was detected in this screen. The requirement of a phosphotransfer reaction between a sensor protein and its cognate response regulator (24, 25) offers support to the function of VprAB as a potential TCS. Supported by the fact that these residues are highly conserved among histidine kinase and response regulator orthologs (25) (see Fig. S2 in the supplemental material), we identified the amino acids involved in phosphorylation in VprA D55 and VprB H222 proteins, which were subsequently mutated to alanine (see Fig. S2 ). Expression of these mutated proteins, VprA D55A and VprB H222A , resulted in the inability to restore the polymyxin resistance phenotype (Fig. 2) . Although additional biochemical studies will be required, these facts strongly support the proposed functional association between VprA and VprB as cognate partners of a signal transduction system. Notably, no additional response regulators that could potentially integrate with the vprAB regulatory circuitry were identified in our polymyxin sensitivity screen (Table 1) .
We demonstrated that VprAB is required for synthesis of the almEFG operon, whose gene products are responsible for glycine modification (9) . The almE transcript, the first gene of the operon, is drastically downregulated in vprA and vprB mutants (Fig. 4A) . A minimal expression level of almE transcript is observed in the vprB mutant. In this scenario, it is possible that VprA is autophosphorylated in the absence of its cognate kinase, using the small molecule phosphodonor acetyl phosphate (25, 51, 52) . However, VprA autophosphorylation is probably low compared to the phosphorylation by its cognate sensor, resulting in both decreased almE synthesis and polymyxin resistance (Fig. 2) . It is tempting to speculate that a minor level of phosphorylated VprA is required to control additional target genes under specific physiological conditions. For instance, VprAB TCS is conserved among Vibrio species (see Table S1 in the supplemental material); however, its role in polymyxin resistance in other species is unknown. By complementation analysis, VprA and VprB expression in trans restored partial almE synthesis compared to the wild type (Fig. 4A) . Although this lower level of transcription might be an effect of the low-copy-number plasmid, it was a sufficient amount of vprA-dependent almE synthesis to restore polymyxin resistance (Fig. 2) . We further provide biochemical evidence that establishes a direct mechanistic link between VprA and its regulation of AlmE expression. VprA binds to the promoter of the almEFG operon ( Fig. 4B and C) , and mass spectrometry analysis showed that mutants of VprAB TCS are defective in their ability to modify their lipid A structure with glycine moieties (Fig. 3) . Overall, this study establishes that the VprAB TCS positively regulates the almEFG operon to control glycine-lipid A modification (Fig. 7) .
Vibrio typically inhabits aquatic ecosystems, most often associated with aquatic fauna before infection of the human host. Due to this wide range of conditions, Vibrio likely has evolved adaptive responses to various extracellular cues in order to promote survival and overall fitness during its infection cycle (53) (54) (55) . Host environmental cues that regulate lipid A modification in Vibrio cholerae are relatively unknown. Therefore, our evaluation included some cues known to regulate lipid A modification in other microorganisms that might regulate the expression of vprAB and almEFG. Our finding reveals that vprA and almE are expressed constitutively in wild-type cells, and their levels of synthesis are significantly altered in the presence of specific stimuli. El Tor V. cholerae may maintain a basal level of glycinylated lipid A on their surfaces but still respond to CAMP-directed membrane disruption by upregulating VprAB-dependent genes.
Changes in pH are well-known environmental signals for bacteria (56, 57) . Mildly acidic pH activates PhoPQ and PmrAB TCSs, promoting modification of lipid A (30, 58) in S. enterica. Vibrio is sensitive to growth in an acidic environment (pH 2.5) (59) but exhibits an adaptive response to survive in mildly acidic pH (pH 4.5) (60, 61) . Bile is also a known environmental signal that downregulates the production of virulence factors in Vibrio cholerae (62) (63) (64) (65) . Transcription of vprA decreases in response to mildly acidic pH 5.8 and to 0.2% bile. Further, similar levels of downregulation are observed for almE transcription (Fig. 5) . These transcriptional profiles support VprAB and AlmEFG as virulence factors in V. cholerae. This is the first study to identify a lipid A modification regulatory pathway in V. cholerae and, importantly, to establish a link between lipid A modification and pathogenesis. Particularly, the recently identified almEFG lipid A modification operon has a striking contribution to colonization in vivo. The reduced intesti-nal colonization exhibited by vprA and almE mutants in two El Tor strains (Fig. 6) suggests that VprAB-dependent lipid A glycine modification is important for El Tor colonization of the mammalian host. The VprAB regulatory system likely regulates the charge of the cell surface to help protect against the host immune system, including CAMPs. Identifying other VprAB-regulated genes and their role in pathogenesis will be an exciting next step in studying V. cholerae pathogenesis.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. V. cholerae O1 El Tor wild-type strains E7946 and C6706 and derived strains are listed in Table S3 in the supplemental material. Vibrio strains were grown in LB medium (Difco) or in LB supplemented with 0.2% Ox-bile (Sigma), 500 M cholate, 500 M deoxycholate, 500 M chenodeoxycholate, 10 mM CaCl 2 , 10 mM MgCl 2 , or 40 M FeSO 4 , where applicable. When buffered LB was used, LB containing 100 mM HEPES or 100 mM Bis-Tris was adjusted to pH 7.0 or 5.8, respectively. V. cholerae was also grown in G56 minimal medium containing 45 mM HEPES (pH 7.5), 10 mM KCl, 10 mM (NH 4 ) 2 SO 4 , 0.2% glucose, 1 mM MgSO 4 , 1 mM CaCl 2 , 0.015 mM FeSO 4 , 0.075 mM thiamine, and 0.15 mM KH 2 PO 4 (20, 66) . In all cases, cells were grown with aeration at 37°C. E. coli strains were grown in LB medium. Antibiotics streptomycin (100 g/ml), kanamycin (30 g/ml), and ampicillin (100 g/ml) were used when appropriate.
Standard DNA methods. Genomic DNA was extracted with an Easy DNA kit (Invitrogen). Plasmid DNA was obtained with a QIAprep Spin miniprep kit (Qiagen). PCR products were obtained using Pfu Turbo DNA polymerase (Stratagene) or TaKaRa Ex Taq DNA polymerase (TaKaRa). PCR products were purified from an agarose gel using a QIAquick PCR gel extraction kit (Qiagen). Custom DNA oligonucleotides (see Table S4 in the supplemental material) were purchased from Sigma-Aldrich. Restriction endonucleases and T4 DNA ligase were obtained from New England Biolabs Inc. (NEB). The QuikChange site-directed mutagenesis system (Stratagene) was used to introduce in vitro point mutations per the manufacturer's instructions. Nucleic acid quantification was carried out using NanoDrop 8000 (Thermo Scientific).
Plasmid constructs. For complementation analysis, the open reading frames containing an additional 20 bp upstream were amplified using primers indicated in Table S4 in the supplemental material and C6706 genomic DNA as the template. Most of the PCR products were digested with XhoI and XbaI restriction enzymes. In the case of vc1319 (vprB), the PCR product was digested with EcoRI and BamHI, whereas the vc1320 (vprA) reaction product was digested with HindIII and KpnI. Each of the digested PCR fragments was cloned into the low-copy-number plasmid pWSK29 (67) . For the vc2731 and vc2732 genes, the open reading frames carrying a ribosomal binding site from pET21a were cloned into pWSK29 at the BamHI and EcoRI sites. The resulting plasmids (see Table S3 in the supplemental material) were introduced into their respective Vibrio mutant backgrounds by electrotransformation.
For VprA-His 6 protein expression, the coding region of the vprA gene was amplified using primers vc1320-HisF-R (see Table S4 ) and C6706 genomic DNA as the template. The resulting 750-bp PCR product was digested with NdeI and HindIII restriction endonucleases and cloned into the expression plasmid pET21a (see Table S3 ). The generated plasmid pET-1320 results in expression of VprA with a C-terminal His 6 tag.
A DNA fragment encoding the C-terminally His-tagged VprA and carrying its native ribosome binding site (RBS) was generated using primers vprA-KpnIF and vprAHis-Hind3R (see Table S4 ). The PCR product was digested with KpnI and HindIII endonucleases and ligated into the medium-copy-number plasmid pBAD24, resulting in the plasmid pBADVprA. Expression plasmids pW1319 and pW1320 were subsequently modified by site-directed mutagenesis using the QuikChange kit (Stratagene) with primers listed in Table S4 in the supplemental material.
For construction of a suicide vector containing the unmarked deleted vprA gene, E7946 genomic DNA was used as the template followed by the splicing by overhang extension (SOE) PCR method (68) . Approximately 500-bp flanking regions of vprA were amplified by PCR using upvprAF-R and downvprAF-R primers (see Table S4 ). The gene deletion included 675 bp of the 705 bp of the vprA coding region, retaining 12 bp at the 5= end and the last 18 bp at the 3= end. Upstream and downstream PCR products were annealed and amplified by SOE PCR using upvprAFdownvprAR primers (see Table S4 ). The resulting~1,000-bp amplicon was subcloned into pGEM-T Easy vector (Promega). The DNA fragment containing the unmarked deleted gene was digested with ApaI and SpeI restriction enzymes and ligated into the counterselectable suicide plasmid pMW91 (69) , generating the pWMvprA plasmid (see Table S3 ).
Construction of vprA deletion mutants. To construct Vibrio cholerae strains harboring the unmarked deletion of vprA (see Table S3 ), the suicide vector pWMVprA was conjugated from SM10 pir into the E7946 strain as previously described (69, 70) . Clean deletions were confirmed by PCR using genomic DNA from candidate mutants.
Expression and purification of C-terminal VprA-His 6 protein fusion. For overexpression of VprA-His 6 , the E. coli host strain HMS174(DE3) carrying the plasmid pET-1320 was grown in LB broth supplemented with ampicillin. During exponential growth (OD 600 of 0.6 to 0.7), 1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to induce the expression of VprA-His 6 . After 2 h of induction at 37°C, cells were harvested at 10,000 ϫ g for 10 min at 4°C followed by one wash in 1ϫ PBS buffer (pH 7.4). The resulting pellet was resuspended in cold binding buffer (20 mM HEPES [pH 7.4], 0.5 M NaCl, 20 mM imidazole) supplemented with complete EDTA-free protease inhibitor cocktail tablets (Roche). Cells were lysed by three cycles of French pressure at 30,000 lb/ in 2 using a chilled pressure cell. The resulting crude cell extract was centrifuged at 10,000 ϫ g for 15 min at 4°C. The cell extract supernatant was filtered through a 0.45-m-pore-size filter (Millipore), transferred to a 1.0-ml HisTrap-FF affinity column (GE Healthcare), and purified using an AKTA FLPC purification system (GE Healthcare). Target protein was eluted with a linear gradient of elution buffer (20 mM HEPES, 0.5 M NaCl, 500 mM imidazole, pH 7.4). The resulting fractions containing purified protein were dialyzed against 20 mM HEPES (pH 7.4) and concentrated using an Amicon Ultra-15 centrifugal filter device with a 3,000-molecular-weight cutoff (Millipore). Proteins were evaluated using 4 to 12% NuPAGE Bis-Tris gels (Invitrogen) and visualized by Coomassie blue staining.
DNA-protein interaction assays. The 130-bp promoter region of almE (P almE ) was obtained by PCR amplification using primers Prom1579F-R (see Table S4 in the supplemental material) and C6706 genomic DNA as the template. This product was gel purified and digested at the 5= end with EcoRI. The digested probe was purified using phenol: chloroform (71) . Five pmol of EcoRI-digested probe was dephosphorylated and labeled with [␥-32 P]ATP (Amersham) using a DNA 5=-endlabeling system (Promega). Removal of unincorporated nucleotides was carried out using NucAway spin columns (Ambion, Inc.). The labeled product was diluted 1:10 for the binding assay. Likewise, probe without labeling was used as a specific competitor. For a nonspecific competitor, a region of 199 bp was obtained by PCR amplification using primers vca0862F-R (see Table S4 ). For cold competition, a 10-fold molar excess of unlabeled probe was added to the binding reaction.
The differential radial capillary action of ligand assay (DRaCALA) (26) reaction was performed by mixing VprA-His 6 protein in modified binding buffer containing 5 mM HEPES (pH 7.9), 40 mM KCl, 1 mM dithiothreitol (DTT), 0.1 mM EDTA, and 5% glycerol (72), preincubated for 10 min at room temperature before addition of 0.5 nM 32 P-DNA probe. The unlabeled DNA probe was included when necessary. A total of 20 l of binding reaction mixture was incubated for 10 min before a 5-l aliquot was loaded onto a nitrocellulose membrane. The dried membrane was exposed to a phosphorimager screen to visualize DNA binding. Binding reactions used for DRaCALA were also used for EMSA. A total of 10 l of binding reaction was loaded onto a 6% retardation gel (Invitrogen), and the gel ran for 13 min at 300 V at a temperature lower than 30°C.
Total RNA isolation and quantitative RT-PCR. Overnight cell cultures were diluted 1:100 in LB medium and grown to an OD 600 of 0.5. Cells were harvested, washed, diluted in fresh LB medium to an OD 600 of 0.1, and grown to an optical density of 0.5. Cells were harvested, and total RNA was extracted with the SV Total RNA isolation system (Promega) followed by RQ1 RNase-free DNase (Promega) treatment to eliminate residual DNA contamination. cDNA synthesis was performed with the high-capacity cDNA reverse transcription (RT) kit (AB Applied Biosystems). The quantification of target gene by quantitative PCR (qPCR) was performed using 2ϫ SYBR green PCR master mix (AB Applied Biosystems) and specific primers for each transcript (see Table S4 in the supplemental material). Data analysis was performed using the ABI 7900HT Fast real-time PCR system and Software Sequence Detection Systems (SDS) version 2.4 (AB Applied Biosystems). The relative expression ratio of the target transcript was calculated in comparison to the gyrA transcript as the reference gene following the Pfaffl method (73) .
Screening for polymyxin-susceptible mutants and MIC determination. A 96-well microtiter plate assay was used to establish mutant susceptibility to polymyxin B. Each well, containing 200 l of LB medium and supplemented with 50 g/ml polymyxin, was inoculated by replica plate by using the C6706 nonredundant transposon insertion library (a total of 3,156 mutants) (18) . Plates were incubated at 37°C with shaking at 250 rpm. After 16 h, the OD 600 was read using a microplate reader (BioTek). Candidate mutants with decreased growth, determined by an OD 600 of Ͻ0.2, were considered susceptible to polymyxin. The MIC was determined using Etest gradient polymyxin B strips (AB Biodisk). For this purpose, cells were grown overnight followed by a dilution of 1:100 in LB medium. Cells were grown to mid-exponential growth and diluted 1:10, and an aliquot was plated on LB agar. For complementation analysis, cells were plated on LB agar containing proper antibiotics and 0.2% arabinose when necessary. A polymyxin B Etest gradient strip was applied onto inoculated plates and incubated at 37°C, and the MIC was evaluated after 16 h.
Isolation of lipid A and mass spectrometry analysis. Cultures were grown at 37°C until an OD 600 of 0.8 to 1.0. Bacteria were harvested at 10,000 ϫ g for 10 min. Lipid A extraction was carried out by mild acidic hydrolysis as previously described (20, 74) . Lipids were analyzed using a MALDI-TOF/TOF (ABI 4700 Proteomic Analyzer) mass spectrometer in the negative-ion linear mode as previously described (12) .
In vivo colonization assay. All animal studies were carried out under protocols approved by the Institutional Animal Care and Use Committee at the University of Texas at Austin in accordance with NIH guidelines. The suckling mouse colonization competition assay was performed with El Tor and derived mutant strains as previously described (75) . Briefly, a 1:1 mixture of approximately 5 ϫ 10 4 CFU mutant (lacZ Ϫ ) and 5 ϫ 10 4 CFU C6706 wild-type (lacZ ϩ ) bacteria was intragastrically inoculated into the stomach of 5-to 6-day-old CD1 suckling mice (Charles River). An aliquot of the inoculum was serially diluted and plated onto selective LB agar containing streptomycin and 20 g/ml 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) to verify the input ratio. After 16 h of colonization, the small intestine was removed and homogenized. Aliquots of the homogenates were plated on selective LB agar and incubated at 37°C, followed by the evaluation of the output ratio after 16 h. Competition index (CI) and statistical significance were determined as previously described (76) .
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